Gm16702 Gene Detail

Summary

• Symbol
  Gm16702
• Name
  predicted gene, 16702
• Synonyms
  AU016609

• Feature Type
  lncRNA gene
• IDs
  MGI:4439626
  NCBI Gene: 100504601
• Alliance
  gene page

Location &
Maps

• Sequence Map
  Chr17:8597877-8608300 bp, - strand

  From NCBI annotation of GRCm39
  

• View this region in JBrowse
  

• Genome Browsers
  Ensembl | UCSC | NCBI

• Genetic Map
  Chromosome 17, 4.92 cM
• Mapping Data
  2 experiments

Strain
Comparison

• SNPs within 2kb
  363 from dbSNP Build 142
• Strain Annotations
  1

Strain	Gene Model ID	Feature Type	Coordinates
C57BL/6J	MGI_C57BL6J_4439626	lncRNA gene	Chr17:8597877-8608300 (-)
129S1/SvImJ	no annotation
A/J	no annotation
AKR/J	no annotation
BALB/cJ	no annotation
C3H/HeJ	no annotation
C57BL/6NJ	no annotation
CAROLI/EiJ	no annotation
CAST/EiJ	no annotation
CBA/J	no annotation
DBA/2J	no annotation
FVB/NJ	no annotation
LP/J	no annotation
NOD/ShiLtJ	no annotation
NZO/HlLtJ	no annotation
PWK/PhJ	no annotation
SPRET/EiJ	no annotation
WSB/EiJ	no annotation

Human Diseases

• References
  6 with disease annotations

Mutations,
Alleles, and
Phenotypes

• Phenotype Summary
  350 phenotype references
  

• All Mutations and Alleles
  3
• Gene trapped
  2
• Radiation induced
  1
• Genomic Mutations
  1 involving Gm16702
• Find Mice (IMSR)
  0 strains or lines available

Expression

• cDNA Data
  2

• Other Mouse Links
  GEO

Sequences &
Gene Models

• All Sequences
  5
• RefSeq
  1

• NCBI Gene
  100504601

Representative Sequences			Length	Strain/Species
genomic	100504601	NCBI Gene Model | MGI Sequence Detail	10424	C57BL/6J
transcript	NR_045795	RefSeq | MGI Sequence Detail	2384	ZRU/MplStud

Molecular
Reagents

• All nucleic 2

  cDNA 2

  
  

  Microarray probesets 1

Other
Accession IDs

MGI:3035494

References

• Summaries
  All 357

  Diseases 6

  Phenotypes 350
• Earliest
  J:30229 Davisson MT, et al., Segmental trisomy as a mouse model for Down syndrome. Prog Clin Biol Res. 1993;384:117-33
• Latest
  J:354984 Emili M, et al., Reversal of neurodevelopmental impairment and cognitive enhancement by pharmacological intervention with the polyphenol polydatin in a Down syndrome model. Neuropharmacology. 2024 Sep 27;261:110170